The acquisition of Applied BioMath is likely to be viewed positively as it enhances Certara's service offerings in the biotech and pharmaceutical space. The lack of financial details may limit the ability to fully assess the impact, but strategically, the acquisition is likely to be beneficial. The news could lead to a short-term positive sentiment among investors, potentially driving the stock price up.